BBLG - Bone Biologics Corp logo

BBLG

Bone Biologics Corp

Net โ€”top 1%Rev โ€”top 1%10Y
Hold

Bone Biologics Corp develops medical devices for bone regeneration in spinal fusion. Its lead product, NELL-1/DBM, aids bone growth, targeting spine surgeons and patients with bone defects or conditions. The company also explores treatments for osteoporosis.

โš•๏ธ Healthcare NASDAQ Listed 2016 $ USD
$1,000 invested 10 years ago โ†’$128today

Score Overview

1 Year
Scoreโ€”
Net Growth24.39%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth-70.38%
Net Trend80%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendNever
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growthโ€”
Net Trendโ€”
Net Income Consistency
Rev Growthโ€”
Rev Trendโ€”
Revenue Consistency
All Time
Scoreโ€”
Net Growth87.99%
Net Trend89%
Net Income Consistency
Rev Growthโ€”
Rev TrendNever
Revenue Consistency

See the full market ranking โ†’

Bone Biologics Corp fundamental performance

Across Bone Biologics Corp's full reported history, from 2016 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 25M to -$ 3M. Revenue increased in 0% of the years measured; net income in 89%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 0.66โ€”
1 Year2025-08-12
$ 2.34-71.88%
5 Years2021-03-19
$ 7.50-91.23%
10 Years2016-08-08
$ 5.15-87.22%
All Time2016-03-31
$ 4.10-83.95%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2025$ 0.00-$ 3M$ 5M
2024$ 0.00-$ 4M$ 3M
2023$ 0.00-$ 8M$ 3M
2022$ 0.00-$ 1M$ 7M
2021$ 0.00-$ 1M$ 6M
2020$ 0.00-$ 1M
2019$ 0.00-$ 3M$ 24.14K
2018$ 0.00-$ 4M$ 955.37K
2017$ 0.00-$ 7M$ 690.28K
IPO2016$ 0.00-$ 25M$ 620.38K

Explore beyond BBLG

You're looking at Bone Biologics Corp. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies